Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Circulating dividing plasma ce...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Circulating dividing plasma cells with giant dumbbell‐shaped nuclei

Circulating dividing plasma cells with giant dumbbell‐shaped nuclei

Bibliographic Details
Main Authors: Elisa Lin, Prasad Koduru, Mingyi Chen
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:eJHaem
Subjects:
clinical
multiple myeloma
myeloma
Online Access:https://doi.org/10.1002/jha2.330
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1002/jha2.330

Similar Items

  • Flower-Like Plasma Cell Nuclei in Multiple Myeloma
    by: Abibatou Sall, et al.
    Published: (2021-06-01)
  • Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk
    by: Katja Weisel, et al.
    Published: (2020-08-01)
  • Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) in the phase III ASPIRE study
    by: Meletios Dimopoulos, et al.
    Published: (2018-04-01)
  • High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
    by: Maryam Pourabdollah, et al.
    Published: (2016-11-01)
  • Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma—A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone
    by: Tobias S. Slørdahl, et al.
    Published: (2025-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs